Enlivex Ltd.
Pharmaceutical company · Tel Aviv, Israel · Nasdaq: ENLV
Enlivex Ltd. is a pharmaceutical company headquartered in Tel Aviv, Israel. Its earliest recorded incorporation is in 2012. Its shares trade on Nasdaq under the ticker ENLV. It has reported private securities offerings to the US SEC, most recently $6.7 million sold in a notice filed in 2016.
Enlivex at a glance
What does Enlivex do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $6.7 million sold (2016).
Frequently asked questions about Enlivex
Where is Enlivex headquartered?
Enlivex Ltd. is headquartered in Tel Aviv, Israel.
What does Enlivex do?
Enlivex Ltd. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Enlivex a public company?
Yes. Enlivex Ltd. trades on Nasdaq under the ticker ENLV.
When was Enlivex founded?
The earliest incorporation on record for Enlivex Ltd. is in 2012, according to public company registers.
Similar companies
- RedHill Biopharma Ltd.Tel Aviv, Israel
- Chemomab Therapeutics Ltd.Tel Aviv, Israel
- Nasus Pharma LtdTel Aviv, Israel
- PRF Technologies Ltd.Tel Aviv, Israel
- Teva Pharmaceutical Industries LtdTel Aviv, Israel
- SciSparc Ltd.Tel Aviv, Israel
- UroGen Pharma Ltd.Ra'anana, Central District, Israel
- MediWound Ltd.Yavné, Central District, Israel
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences